Cargando…
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries
BACKGROUND: Herd immunity (HI) is a key benefit of vaccination programs, but the effects are not routinely included in cost-effectiveness analyses (CEAs). OBJECTIVE: This study investigated how the inclusion of HI in CEAs may influence the reported value of immunizations in low- and middle-income co...
Autores principales: | Ma, Siyu, Lavelle, Tara A., Ollendorf, Daniel A., Lin, Pei-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743090/ https://www.ncbi.nlm.nih.gov/pubmed/35001292 http://dx.doi.org/10.1007/s40258-021-00711-y |
Ejemplares similares
-
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023) -
The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020) -
Screening for breast cancer: Cost-effective solutions for low- & middle-income countries
por: Mishra, Gauravi A., et al.
Publicado: (2021) -
Cost-Effectiveness Analysis of COVID-19 Vaccination in Low- and Middle-Income Countries
por: Utami, Auliasari M, et al.
Publicado: (2022) -
Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries
por: Kim, Sun-Young, et al.
Publicado: (2021)